As a Cardiac Nurse Practitioner, Kerry brings her passion for patient advocacy to detailed medical assessment and management within our Dysautonomia and Immune pathways. She works with people whose standing tolerance has fallen away—not from deconditioning, but from autonomic dysregulation where the nervous system no longer manages blood pressure and heart rate properly. Where cognitive function disappears after 20 minutes upright. Where showering requires recovery. Where viral illness triggered something that hasn't resolved in months or years.
Kerry's approach is deeply empathetic, drawing on her understanding of what it means to navigate a healthcare system that often dismisses invisible illnesses. She offers hope and direction to those who have felt lost in their symptoms or let down by previous healthcare experiences. Working collaboratively with patients, she ensures they never feel alone in their healthcare journey while giving them the tools to actively participate in their recovery.
Kerry has a special interest in supporting those with autonomic dysfunction and cardiac symptomatology, with particular focus on POTS and orthostatic intolerance. She’s seen how frequently individuals with POTS slip through the cracks of conventional care models and the medical trauma that often emerges after years of misunderstanding or medical gaslighting.
Her approach to POTS and dysautonomia is holistic and practical, recognising that effective care requires both immediate symptom relief and sustainable recovery strategies. She provides patients with concrete, actionable tools—beyond just rest and pacing—that create meaningful improvements in daily functioning.
Her assessments examine the full cascade of autonomic dysfunction: how standing triggers symptom exacerbation, how blood pooling affects multiple organ systems, how blood pressure contributes to the picture. She identifies which dysautonomia subtype predominates—hyperadrenergic, neuropathic, or hypovolemic—shaping treatment accordingly.
Kerry's cardiac background enables her to differentiate between autonomic dysfunction and structural heart disease, interpret cardiac testing in the context of autonomic symptoms, and manage the cardiovascular medications that form the foundation of many POTS treatment protocols.
Understanding that MCAS and dysautonomia frequently coexist, Kerry assesses for mast cell activation patterns that amplify autonomic symptoms. Her treatment approach addresses both systems concurrently—autonomic medications alongside mast cell stabilization, fluid management accounting for increased blood vessel permeability, exercise modified for post-exertional symptom exacerbation. She coordinates care within Biio's immune pathway when autoimmune markers or post-viral triggers complicate the clinical picture.
Kerry recognises that dysautonomia rarely exists in isolation. She collaborates across pathways: coordinating with hypermobility physiotherapists when lax connective tissue contributes to venous pooling, working with the hormonal pathway when estrogen fluctuations worsen symptoms, partnering with neurodivergent health specialists when interoception differences affect symptom recognition.